Human Genome Sciences (HGSI) Gets Response from U.S. FDA for ZALBIN BLA

June 14, 2010 6:51 AM EDT Send to a Friend
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has received preliminary written feedback from the U.S. Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login